Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline-Reference-Cited by-同舟云学术

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline

Published:2023-07 Issue:3 Volume:21 Page:306-314
ISSN:1541-4094
Container-title:FOCUS
language:en
Short-container-title:FOC

Author:

Feduccia Allison A.¹,Jerome Lisa¹,Yazar-Klosinski Berra¹,Emerson Amy¹,Mithoefer Michael C.¹,Doblin Rick¹

Affiliation:

1. Department of Research Development and Regulatory Affairs, MAPS Public Benefit Corporation, Santa Cruz, CA, United States (Feduccia, Jerome). Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, United States (Yazar-Klosinski, Doblin). MAPS Public Benefit Corporation, Santa Cruz, CA, United States (Emerson). Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States (Mithoefer).

Publisher

American Psychiatric Association Publishing

Subject

General Medicine

Reference60 articles.

1. Posttraumatic Stress Disorder–Related Hospitalizations in the United States (2002–2011)

2. Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

3. Combat Duty in Iraq and Afghanistan, Mental Health Problems, and Barriers to Care

4. Efficacy and Safety of Sertraline Treatment of Posttraumatic Stress Disorder

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychostimulants and social behaviors;Frontiers in Pharmacology;2024-04-25

2. The value of using real-world evidence as a source of clinical evidence in the European medical device regulations: a mixed methods study;Expert Review of Medical Devices;2023-12-05

3. Can research on entactogens contribute to a deeper understanding of human sexuality?;Pharmacological Reports;2023-11-08

4. MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence;Diseases;2023-11-03